Sylogist Ltd.
SYZLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $163 | $206 | $192 | $208 |
| - Cash | $10 | $5 | $10 | $13 |
| + Debt | $14 | $19 | $19 | $19 |
| Enterprise Value | $167 | $220 | $201 | $214 |
| Revenue | $11 | $16 | $16 | $15 |
| % Growth | -27.2% | -4% | 6.5% | – |
| Gross Profit | $5 | $9 | $10 | $9 |
| % Margin | 44% | 57.7% | 59.1% | 58.9% |
| EBITDA | $2 | $1 | $2 | $3 |
| % Margin | 17.7% | 9% | 14.8% | 16.6% |
| Net Income | -$1 | -$2 | -$1 | $1 |
| % Margin | -5.6% | -12.3% | -5.7% | 4.8% |
| EPS Diluted | -0.027 | -0.082 | -0.04 | 0.03 |
| % Growth | 66.8% | -105% | -233.8% | – |
| Operating Cash Flow | $11 | -$4 | $1 | $1 |
| Capital Expenditures | -$1 | -$1 | -$0 | -$0 |
| Free Cash Flow | $10 | -$5 | $1 | $1 |